China urged the incoming Trump administration to work together, as Trump said COVID-19 strained his once strong ties with Xi Jinping, calling their relationship "a bridge too far" after the pandemic.
China's top diplomat said on Tuesday he hoped the incoming Trump administration would "make the right choice" and work with Beijing, hours after Donald Trump told reporters the COVID-19 pandemic had strained his relationship with "friend" Xi Jinping.
"We hope the new U.S. administration will make the right choice and work with China in a mutually-beneficial manner to remove disruptions and overcome obstacles," Foreign Minister Wang Yi told a forum in Beijing, according to a statement from his ministry.
The remarks followed President-elect Trump telling his first news conference since his election victory six weeks ago that Chinese President Xi Jinping had been a friend of his and that "he is an amazing guy" but that relations had been strained.
"We had a very good relationship until COVID," Trump told reporters gathered at his Mar-a-Lago resort in Florida on Monday when asked whether Xi would attend his inauguration. "COVID didn't end the relationship, but it was a bridge too far for me."
Read next
18:00
China - US
Stephen Orlins, president of the National Committee on United States-China Relations (NCUSCR), stated that China and the United States should cooperate in the field of artificial intelligence (AI) to avoid duplicating efforts.
13:00
Japan
Japan has lodged an official protest with China over a statement that it claims misquoted Prime Minister Shigeru Ishiba’s comments during his meeting with Chinese Foreign Minister Wang Yi on Friday. Japan’s top government spokesperson confirmed the protest on Monday.
12:30
China
China is working to reassure top U.S. corporate leaders about its strong business potential amid ongoing geopolitical tensions and a slowing domestic economy.
14:30
Tencent
Chinese tech giant Tencent on Friday night launched the official version of its T1 reasoning model, marking a significant step in its bid to strengthen its foothold in the rapidly evolving artificial intelligence landscape.
12:15
AstraZeneca, opens new tab said it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year.
What is your opinion on this topic?
Leave the first comment